The board of directors of the Wai Chun Bio-Technology Limited announced that Mr. Lam Ka Chun, currently an executive director of the Company, in addition to such role, has be appointed as chairman of the Board and chief executive officer of the Company with effect from 1 November 2023. Mr. Lam, aged 32, had studied chemistry at Imperial College London from 2009 to 2011 and he had served as chief executive officer in various companies from 2011 to 2017 which has accumulated extensive experience in projects investment and management. Mr. Lam has been the managing directors of the Company and Wai Chun Group Holdings Limited since 2017 and is responsible for the investment and operation of the listed companies.

Mr. Lam has been appointed as the chairman of the board of directors, the chief executive officer and an executive director of Wai Chun Group Holdings Limited on 27 October 2023. Mr. Lam is the son of Mr. Lam Ching Kui. As at the date of this announcement, Chinese Success Limited, the substantial shareholder of the Company within the meaning of Part XV of the Securities and Futures Ordinance and the controlling shareholder of the Company, is wholly owned by Wai Chun Investment Fund.

Wai Chun Investment Fund is wholly owned by Mr. Lam Ching Kui.